People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalized from a heart attack or heart failure, regardless of their body mass index, according to new ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat substance abuse disorders, psychosis, infections, cancer, and dementia.

A study led by researchers from the University of Granada, carried out in collaboration with the University of Castilla-La ...

A new study found people with type 2 diabetes who used drugs like Ozempic had a reduced risk of 42 health conditions or ...

Long working hours are linked to a 29% increase in deaths from stroke and ischemic heart disease since 2000, as stated by WHO ...

Snow shovelling is an unavoidable reality for most Canadians, but this common winter chore can come with some serious health ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

Here we take a look back at some of our research breakthroughs of 2024. January: Diet in childhood linked to blood vessel damage in teenage years We kicked off 2024 with research highlighting the ...

Navigating the world of nutrition can feel like trying to find your way through a maze of myths and misconceptions. Before ...

The benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...